Neutralising antibodies that block CD36 completely inhibited the formation of metastasis in orthotopic mouse models of human oral cancer, and CD36 inhibition impaired metastasis in human melanoma and breast cancer-derived tumours. Here, CD36 is linked to breast cancer.